MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to xencor, inc
-$91,923K
(60.48%↑ Y/Y)
Net loss
attributable to...
-$214K
(94.54%↑ Y/Y)
Net loss including
noncontrolling interest
-$92,137K
(61.05%↑ Y/Y)
Gain (loss) on
marketable equity...
$101,514K
(423.07%↑ Y/Y)
Interest income
$27,524K
(-13.80%↓ Y/Y)
Loss before income
tax expense and...
-$89,633K
(61.85%↑ Y/Y)
Income tax expense
$2,504K
(54.85%↑ Y/Y)
Total other income
(expense)
$87,869K
(255.48%↑ Y/Y)
Alexion
Pharmaceuticals Inc.
$70,070K
Incyte Corporation
$51,696K
Vir
$2,010K
Shanghai Mabgeek Biotech
Co.Ltd.
$1,800K
Interest expense
$31,927K
(-12.87%↓ Y/Y)
Asset impairment
charges
$9,169K
Other, net
-$73K
(-246.00%↓ Y/Y)
Operating loss
-$177,502K
(0.51%↑ Y/Y)
Collaborations, milestones, and
royalties
$125,576K
(13.65%↑ Y/Y)
Total operating
expenses
$303,078K
(4.91%↑ Y/Y)
Research and development
$239,434K
(5.16%↑ Y/Y)
General and
administrative
$63,644K
(3.97%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Xencor Inc (XNCR)
Xencor Inc (XNCR)